{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:01:39Z","timestamp":1785232899524,"version":"3.55.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000090","name":"United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["PC210168, PC230673"],"award-info":[{"award-number":["PC210168, PC230673"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA285772-01"],"award-info":[{"award-number":["1R01CA285772-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["2023CHAL4150"],"award-info":[{"award-number":["2023CHAL4150"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1165762, APP2001098, APP2010551"],"award-info":[{"award-number":["APP1165762, APP2001098, APP2010551"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002337","name":"Petre Foundation","doi-asserted-by":"publisher","award":["Petre Chair"],"award-info":[{"award-number":["Petre Chair"]}],"id":[{"id":"10.13039\/501100002337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004365","name":"University of Sydney | Sydney Medical School","doi-asserted-by":"publisher","award":["International Scholarship"],"award-info":[{"award-number":["International Scholarship"]}],"id":[{"id":"10.13039\/501100004365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Genetic germline testing is restricted for African patients. Lack of ancestrally relevant genomic data perpetuated by African diversity has resulted in European-biased curated clinical variant databases and pathogenic prediction guidelines. While numerous variant pathogenicity prediction tools (VPPTs) exist, their performance has yet to be established within the context of African diversity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>To address this limitation, we assessed 54 VPPTs for predictive performance (sensitivity, specificity, false positive and negative rates) across 145,291 known pathogenic or benign variants derived from 50 Southern African and 50 European men matched for advanced prostate cancer. Prioritising VPPTs for optimal ancestral performance, we screened 5.3 million variants of unknown significance for predicted functional and oncogenic potential.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We observe a 2.1- and 4.1-fold increase in the number of known and predicted rare pathogenic or benign variants, respectively, against a 1.6-fold decrease in the number of available interrogated variants in our European over African data. Although sensitivity was significantly lower for our African data overall (0.66 <jats:italic>vs<\/jats:italic> 0.71, <jats:italic>p<\/jats:italic>\u2009=\u20099.86E-06), MetaSVM, CADD, Eigen-raw, BayesDel-noAF, phyloP100way-vertebrate and MVP outperformed irrespective of ancestry. Conversely, MutationTaster, DANN, LRT and GERP-RS were African-specific top performers, while MutationAssessor, PROVEAN, LIST-S2 and REVEL are European-specific. Using these pathogenic prediction workflows, we narrow the ancestral gap for potentially deleterious and oncogenic variant prediction in favour of our African data by 1.15- and 1.1-fold, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Although VPPT sensitivity favours European data, our findings provide guidelines for VPPT selection to maximise rare pathogenic variant prediction for African disease studies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1038\/s43856-025-00883-x","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T13:26:05Z","timestamp":1746537965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluating variant pathogenicity prediction tools to establish African inclusive guidelines for germline genetic testing"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8752-6027","authenticated-orcid":false,"given":"Kangping","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8557-3649","authenticated-orcid":false,"given":"Kazzem","family":"Gheybi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8485-6556","authenticated-orcid":false,"given":"Pamela X. Y.","family":"Soh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4524-7280","authenticated-orcid":false,"given":"Vanessa M.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"883_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/j.seminoncol.2023.12.001","volume":"50","author":"J Shain","year":"2023","unstructured":"Shain, J. et al. Cancer genetic mutation prevalence in sub-Saharan Africa: a review of existing data. Semin. Oncol. 50, 123\u2013130 (2023).","journal-title":"Semin. Oncol."},{"key":"883_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cell.2019.02.048","volume":"177","author":"G Sirugo","year":"2019","unstructured":"Sirugo, G., Williams, S. M. & Tishkoff, S. A. The missing diversity in human genetic studies. Cell 177, 26\u201331 (2019).","journal-title":"Cell"},{"key":"883_CR3","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/pros.22806","volume":"74","author":"EA Tindall","year":"2014","unstructured":"Tindall, E. A. et al. Clinical presentation of prostate cancer in black South Africans. Prostate 74, 880\u2013891 (2014).","journal-title":"Prostate"},{"key":"883_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"883_CR5","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1200\/JCO.20.00046","volume":"38","author":"VN Giri","year":"2020","unstructured":"Giri, V. N. et al. Implementation of germline testing for prostate cancer: Philadelphia Prostate Cancer Consensus Conference 2019. J. Clin. Oncol. 38, 2798\u20132811 (2020).","journal-title":"J. Clin. Oncol."},{"key":"883_CR6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41588-020-0580-y","volume":"52","author":"MC Mills","year":"2020","unstructured":"Mills, M. C. & Rahal, C. The GWAS Diversity Monitor tracks diversity by disease in real time. Nat. Genet. 52, 242\u2013243 (2020).","journal-title":"Nat. Genet."},{"key":"883_CR7","doi-asserted-by":"publisher","unstructured":"Health in Africa. Nat. Commun. 15, 967 https:\/\/doi.org\/10.1038\/s41467-024-45268-1 (2024).","DOI":"10.1038\/s41467-024-45268-1"},{"key":"883_CR8","doi-asserted-by":"publisher","first-page":"144","DOI":"10.22465\/juo.244800340017","volume":"22","author":"VM Hayes","year":"2024","unstructured":"Hayes, V. M. et al. Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: closing the health equity gap through rural community inclusion. J. Urol. Oncol. 22, 144\u2013149 (2024).","journal-title":"J. Urol. Oncol."},{"key":"883_CR9","doi-asserted-by":"publisher","unstructured":"Bergstrom, A. et al. Insights into human genetic variation and population history from 929 diverse genomes. Science 367, https:\/\/doi.org\/10.1126\/science.aay5012 (2020).","DOI":"10.1126\/science.aay5012"},{"key":"883_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41591-021-01672-4","volume":"28","author":"S Fatumo","year":"2022","unstructured":"Fatumo, S. et al. A roadmap to increase diversity in genomic studies. Nat. Med. 28, 243\u2013250 (2022).","journal-title":"Nat. Med."},{"key":"883_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"883_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ajhg.2017.01.004","volume":"100","author":"Q Li","year":"2017","unstructured":"Li, Q. & Wang, K. InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines. Am. J. Hum. Genet. 100, 267\u2013280 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"883_CR13","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum, M. J. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062\u2013D1067 (2018).","journal-title":"Nucleic Acids Res."},{"key":"883_CR14","doi-asserted-by":"publisher","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","volume":"44","author":"MJ Landrum","year":"2016","unstructured":"Landrum, M. J. et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 44, D862\u2013D868 (2016).","journal-title":"Nucleic Acids Res."},{"key":"883_CR15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3389\/fgene.2019.00601","volume":"10","author":"CD Bope","year":"2019","unstructured":"Bope, C. D. et al. Dissecting in silico mutation prediction of variants in African genomes: challenges and perspectives. Front. Genet. 10, 601 (2019).","journal-title":"Front. Genet."},{"key":"883_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.6004\/jnccn.2022.7097","volume":"21","author":"K Gheybi","year":"2023","unstructured":"Gheybi, K. et al. Evaluating germline testing panels in southern african males with advanced prostate cancer. J. Natl. Compr. Cancer Netw. 21, 289\u2013296.e283 (2023).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"883_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47993-x","volume":"13","author":"K Gheybi","year":"2023","unstructured":"Gheybi, K. et al. Linking African ancestral substructure to prostate cancer health disparities. Sci. Rep. 13, 20909 (2023).","journal-title":"Sci. Rep."},{"key":"883_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41586-022-05154-6","volume":"609","author":"W Jaratlerdsiri","year":"2022","unstructured":"Jaratlerdsiri, W. et al. African-specific molecular taxonomy of prostate cancer. Nature 609, 552\u2013559 (2022).","journal-title":"Nature"},{"key":"883_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.981005","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu, Y., Yeung, W. S. B., Chiu, P. C. N. & Cao, D. Computational approaches for predicting variant impact: an overview from resources, principles to applications. Front. Genet. 13, 981005 (2022).","journal-title":"Front. Genet."},{"key":"883_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1010327","volume":"13","author":"FAO Garcia","year":"2022","unstructured":"Garcia, F. A. O., de, Andrade, E. S. & Palmero, E. I. Insights on variant analysis in silico tools for pathogenicity prediction. Front. Genet. 13, 1010327 (2022).","journal-title":"Front. Genet."},{"key":"883_CR21","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","volume":"21","author":"EM Schaeffer","year":"2023","unstructured":"Schaeffer, E. M. et al. Prostate cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Cancer Netw. 21, 1067\u20131096 (2023).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"883_CR22","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1534\/genetics.114.164350","volume":"197","author":"A Raj","year":"2014","unstructured":"Raj, A., Stephens, M. & Pritchard, J. K. fastSTRUCTURE: variational inference of population structure in large SNP data sets. Genetics 197, 573\u2013589 (2014).","journal-title":"Genetics"},{"key":"883_CR23","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).","journal-title":"Nucleic Acids Res."},{"key":"883_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00803-9","volume":"12","author":"X Liu","year":"2020","unstructured":"Liu, X., Li, C., Mou, C., Dong, Y. & Tu, Y. dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs. Genome Med. 12, 103 (2020).","journal-title":"Genome Med."},{"key":"883_CR25","unstructured":"R Core Team R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org\/ (2024)."},{"key":"883_CR26","unstructured":"RStudio Team RStudio: Integrated Development for R. RStudio, PBC, Boston, MA. http:\/\/www.rstudio.com\/ (2020)."},{"key":"883_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-018-0531-8","volume":"10","author":"D Tamborero","year":"2018","unstructured":"Tamborero, D. et al. Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations. Genome Med. 10, 25 (2018).","journal-title":"Genome Med."},{"key":"883_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The Ensembl Variant Effect Predictor. Genome Biol. 17, 122 (2016).","journal-title":"Genome Biol."},{"key":"883_CR29","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1215040","volume":"335","author":"DG MacArthur","year":"2012","unstructured":"MacArthur, D. G. et al. A systematic survey of loss-of-function variants in human protein-coding genes. Science 335, 823\u2013828 (2012).","journal-title":"Science"},{"key":"883_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42156-y","volume":"14","author":"LM Blair","year":"2023","unstructured":"Blair, L. M. et al. Oncogenic context shapes the fitness landscape of tumor suppression. Nat. Commun. 14, 6422 (2023).","journal-title":"Nat. Commun."},{"key":"883_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.975478","volume":"9","author":"P Barbosa","year":"2022","unstructured":"Barbosa, P., Ribeiro, M., Carmo-Fonseca, M. & Fonseca, A. Clinical significance of genetic variation in hypertrophic cardiomyopathy: comparison of computational tools to prioritize missense variants. Front. Cardiovasc. Med. 9, 975478 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"883_CR32","doi-asserted-by":"publisher","first-page":"e1006481","DOI":"10.1371\/journal.pcbi.1006481","volume":"15","author":"A Niroula","year":"2019","unstructured":"Niroula, A. & Vihinen, M. How good are pathogenicity predictors in detecting benign variants? PLoS Comput. Biol. 15, e1006481 (2019).","journal-title":"PLoS Comput. Biol."},{"key":"883_CR33","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.gpb.2022.02.002","volume":"21","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Performance comparison of computational methods for the prediction of the function and pathogenicity of non-coding variants. Genom. Proteom. Bioinform. 21, 649\u2013661 (2023).","journal-title":"Genom. Proteom. Bioinform."},{"key":"883_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-023-01454-6","volume":"16","author":"S Cannon","year":"2023","unstructured":"Cannon, S., Williams, M., Gunning, A. C. & Wright, C. F. Evaluation of in silico pathogenicity prediction tools for the classification of small in-frame indels. BMC Med. Genom. 16, 36 (2023).","journal-title":"BMC Med. Genom."},{"key":"883_CR35","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.jmoldx.2020.08.007","volume":"22","author":"V Suybeng","year":"2020","unstructured":"Suybeng, V., Koeppel, F., Harle, A. & Rouleau, E. Comparison of pathogenicity prediction tools on somatic variants. J. Mol. Diagn. 22, 1383\u20131392 (2020).","journal-title":"J. Mol. Diagn."},{"key":"883_CR36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/bja\/aew065","volume":"117","author":"AH Schiemann","year":"2016","unstructured":"Schiemann, A. H. & Stowell, K. M. Comparison of pathogenicity prediction tools on missense variants in RYR1 and CACNA1S associated with malignant hyperthermia. Br. J. Anaesth. 117, 124\u2013128 (2016).","journal-title":"Br. J. Anaesth."},{"key":"883_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41586-019-1714-1","volume":"575","author":"EKF Chan","year":"2019","unstructured":"Chan, E. K. F. et al. Human origins in a southern African palaeo-wetland and first migrations. Nature 575, 185\u2013189 (2019).","journal-title":"Nature"},{"key":"883_CR38","doi-asserted-by":"publisher","first-page":"e1003309","DOI":"10.1371\/journal.pgen.1003309","volume":"9","author":"DC Petersen","year":"2013","unstructured":"Petersen, D. C. et al. Complex patterns of genomic admixture within southern Africa. PLoS Genet. 9, e1003309 (2013).","journal-title":"PLoS Genet."},{"key":"883_CR39","doi-asserted-by":"publisher","first-page":"e1007387","DOI":"10.1371\/journal.pgen.1007387","volume":"14","author":"R Torres","year":"2018","unstructured":"Torres, R., Szpiech, Z. A. & Hernandez, R. D. Human demographic history has amplified the effects of background selection across the genome. PLoS Genet. 14, e1007387 (2018).","journal-title":"PLoS Genet."},{"key":"883_CR40","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1038\/s41588-024-01894-5","volume":"56","author":"SJ Jurgens","year":"2024","unstructured":"Jurgens, S. J. et al. Rare coding variant analysis for human diseases across biobanks and ancestries. Nat. Genet. 56, 1811\u20131820 (2024).","journal-title":"Nat. Genet."},{"key":"883_CR41","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/s41591-022-01835-x","volume":"28","author":"AB Kamiza","year":"2022","unstructured":"Kamiza, A. B. et al. Transferability of genetic risk scores in African populations. Nat. Med. 28, 1163\u20131166 (2022).","journal-title":"Nat. Med."},{"key":"883_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43726-w","volume":"14","author":"PXY Soh","year":"2023","unstructured":"Soh, P. X. Y. et al. Prostate cancer genetic risk and associated aggressive disease in men of African ancestry. Nat. Commun. 14, 8037 (2023).","journal-title":"Nat. Commun."},{"key":"883_CR43","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/humu.24362","volume":"43","author":"D Anderson","year":"2022","unstructured":"Anderson, D. & Lassmann, T. An expanded phenotype centric benchmark of variant prioritisation tools. Hum. Mutat. 43, 539\u2013546 (2022).","journal-title":"Hum. Mutat."},{"key":"883_CR44","doi-asserted-by":"publisher","first-page":"7793","DOI":"10.1093\/nar\/gky678","volume":"46","author":"J Li","year":"2018","unstructured":"Li, J. et al. Performance evaluation of pathogenicity-computation methods for missense variants. Nucleic Acids Res. 46, 7793\u20137804 (2018).","journal-title":"Nucleic Acids Res."},{"key":"883_CR45","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/humu.22768","volume":"36","author":"DG Grimm","year":"2015","unstructured":"Grimm, D. G. et al. The evaluation of tools used to predict the impact of missense variants is hindered by two types of circularity. Hum. Mutat. 36, 513\u2013523 (2015).","journal-title":"Hum. Mutat."},{"key":"883_CR46","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/ng.3477","volume":"48","author":"I Ionita-Laza","year":"2016","unstructured":"Ionita-Laza, I., McCallum, K., Xu, B. & Buxbaum, J. D. A spectral approach integrating functional genomic annotations for coding and noncoding variants. Nat. Genet. 48, 214\u2013220 (2016).","journal-title":"Nat. Genet."},{"key":"883_CR47","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/gim.2013.73","volume":"15","author":"RC Green","year":"2013","unstructured":"Green, R. C. et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 15, 565\u2013574 (2013).","journal-title":"Genet Med."},{"key":"883_CR48","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ajhg.2013.08.006","volume":"93","author":"MO Dorschner","year":"2013","unstructured":"Dorschner, M. O. et al. Actionable, pathogenic incidental findings in 1000 participants\u2019 exomes. Am. J. Hum. Genet. 93, 631\u2013640 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"883_CR49","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1101\/gr.183483.114","volume":"25","author":"LM Amendola","year":"2015","unstructured":"Amendola, L. M. et al. Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Res. 25, 305\u2013315 (2015).","journal-title":"Genome Res."},{"key":"883_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14079-0","volume":"11","author":"M Pinese","year":"2020","unstructured":"Pinese, M. et al. The Medical Genome Reference Bank contains whole genome and phenotype data of 2570 healthy elderly. Nat. Commun. 11, 435 (2020).","journal-title":"Nat. Commun."},{"key":"883_CR51","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"883_CR52","doi-asserted-by":"publisher","unstructured":"Jaiswal, S. & Ebert, B. L. Clonal hematopoiesis in human aging and disease. Science 366, https:\/\/doi.org\/10.1126\/science.aan4673 (2019).","DOI":"10.1126\/science.aan4673"},{"key":"883_CR53","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1101\/gr.176601","volume":"11","author":"PC Ng","year":"2001","unstructured":"Ng, P. C. & Henikoff, S. Predicting deleterious amino acid substitutions. Genome Res. 11, 863\u2013874 (2001).","journal-title":"Genome Res."},{"key":"883_CR54","doi-asserted-by":"publisher","first-page":"e1000471","DOI":"10.1371\/journal.pgen.1000471","volume":"5","author":"G McVicker","year":"2009","unstructured":"McVicker, G., Gordon, D., Davis, C. & Green, P. Widespread genomic signatures of natural selection in hominid evolution. PLoS Genet. 5, e1000471 (2009).","journal-title":"PLoS Genet."},{"key":"883_CR55","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1101\/gr.092619.109","volume":"19","author":"S Chun","year":"2009","unstructured":"Chun, S. & Fay, J. C. Identification of deleterious mutations within three human genomes. Genome Res. 19, 1553\u20131561 (2009).","journal-title":"Genome Res."},{"key":"883_CR56","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1093\/bioinformatics\/btp528","volume":"25","author":"B Li","year":"2009","unstructured":"Li, B. et al. Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics 25, 2744\u20132750 (2009).","journal-title":"Bioinformatics"},{"key":"883_CR57","doi-asserted-by":"publisher","first-page":"i54","DOI":"10.1093\/bioinformatics\/btp190","volume":"25","author":"M Garber","year":"2009","unstructured":"Garber, M. et al. Identifying novel constrained elements by exploiting biased substitution patterns. Bioinformatics 25, i54\u2013i62 (2009).","journal-title":"Bioinformatics"},{"key":"883_CR58","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1101\/gr.097857.109","volume":"20","author":"KS Pollard","year":"2010","unstructured":"Pollard, K. S., Hubisz, M. J., Rosenbloom, K. R. & Siepel, A. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res. 20, 110\u2013121 (2010).","journal-title":"Genome Res."},{"key":"883_CR59","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248\u2013249 (2010).","journal-title":"Nat. Methods"},{"key":"883_CR60","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1093\/nar\/gkr407","volume":"39","author":"B Reva","year":"2011","unstructured":"Reva, B., Antipin, Y. & Sander, C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 39, e118 (2011).","journal-title":"Nucleic Acids Res."},{"key":"883_CR61","doi-asserted-by":"publisher","first-page":"e46688","DOI":"10.1371\/journal.pone.0046688","volume":"7","author":"Y Choi","year":"2012","unstructured":"Choi, Y., Sims, G. E., Murphy, S., Miller, J. R. & Chan, A. P. Predicting the functional effect of amino acid substitutions and indels. PLoS ONE 7, e46688 (2012).","journal-title":"PLoS ONE"},{"key":"883_CR62","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/humu.22225","volume":"34","author":"HA Shihab","year":"2013","unstructured":"Shihab, H. A. et al. Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Hum. Mutat. 34, 57\u201365 (2013).","journal-title":"Hum. Mutat."},{"key":"883_CR63","doi-asserted-by":"publisher","unstructured":"Carter, H., Douville, C., Stenson, P. D., Cooper, D. N. & Karchin, R. Identifying Mendelian disease genes with the variant effect scoring tool. BMC Genom. 14, https:\/\/doi.org\/10.1186\/1471-2164-14-S3-S3 (2013).","DOI":"10.1186\/1471-2164-14-S3-S3"},{"key":"883_CR64","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310\u2013315 (2014).","journal-title":"Nat. Genet."},{"key":"883_CR65","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz, J. M., Cooper, D. N., Schuelke, M. & Seelow, D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat. Methods 11, 361\u2013362 (2014).","journal-title":"Nat. Methods"},{"key":"883_CR66","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/bioinformatics\/btu703","volume":"31","author":"D Quang","year":"2015","unstructured":"Quang, D., Chen, Y. & Xie, X. DANN: a deep learning approach for annotating the pathogenicity of genetic variants. Bioinformatics 31, 761\u2013763 (2015).","journal-title":"Bioinformatics"},{"key":"883_CR67","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1093\/bioinformatics\/btv009","volume":"31","author":"HA Shihab","year":"2015","unstructured":"Shihab, H. A. et al. An integrative approach to predicting the functional effects of non-coding and coding sequence variation. Bioinformatics 31, 1536\u20131543 (2015).","journal-title":"Bioinformatics"},{"key":"883_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/srep10576","volume":"5","author":"Q Lu","year":"2015","unstructured":"Lu, Q. et al. A statistical framework to predict functional non-coding regions in the human genome through integrated analysis of annotation data. Sci. Rep. 5, 10576 (2015).","journal-title":"Sci. Rep."},{"key":"883_CR69","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/ng.3196","volume":"47","author":"B Gulko","year":"2015","unstructured":"Gulko, B., Hubisz, M. J., Gronau, I. & Siepel, A. A method for calculating probabilities of fitness consequences for point mutations across the human genome. Nat. Genet. 47, 276\u2013283 (2015).","journal-title":"Nat. Genet."},{"key":"883_CR70","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1093\/hmg\/ddu733","volume":"24","author":"C Dong","year":"2015","unstructured":"Dong, C. et al. Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. Hum. Mol. Genet. 24, 2125\u20132137 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"883_CR71","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/humu.23158","volume":"38","author":"BJ Feng","year":"2017","unstructured":"Feng, B. J. PERCH: a unified framework for disease gene prioritization. Hum. Mutat. 38, 243\u2013251 (2017).","journal-title":"Hum. Mutat."},{"key":"883_CR72","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1038\/ng.3703","volume":"48","author":"KA Jagadeesh","year":"2016","unstructured":"Jagadeesh, K. A. et al. M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity. Nat. Genet. 48, 1581\u20131586 (2016).","journal-title":"Nat. Genet."},{"key":"883_CR73","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis, N. M. et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am. J. Hum. Genet. 99, 877\u2013885 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"883_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nprot.2015.123","volume":"11","author":"R Vaser","year":"2016","unstructured":"Vaser, R., Adusumalli, S., Leng, S. N., Sikic, M. & Ng, P. C. SIFT missense predictions for genomes. Nat. Protoc. 11, 1\u20139 (2016).","journal-title":"Nat. Protoc."},{"key":"883_CR75","doi-asserted-by":"publisher","first-page":"W201","DOI":"10.1093\/nar\/gkx390","volume":"45","author":"D Raimondi","year":"2017","unstructured":"Raimondi, D. et al. DEOGEN2: prediction and interactive visualization of single amino acid variant deleteriousness in human proteins. Nucleic Acids Res. 45, W201\u2013W206 (2017).","journal-title":"Nucleic Acids Res."},{"key":"883_CR76","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/ng.3810","volume":"49","author":"YF Huang","year":"2017","unstructured":"Huang, Y. F., Gulko, B. & Siepel, A. Fast, scalable prediction of deleterious noncoding variants from functional and population genomic data. Nat. Genet. 49, 618\u2013624 (2017).","journal-title":"Nat. Genet."},{"key":"883_CR77","doi-asserted-by":"publisher","unstructured":"Samocha, K. E. et al. Regional missense constraint improves variant deleteriousness prediction. https:\/\/doi.org\/10.1101\/148353 (2017).","DOI":"10.1101\/148353"},{"key":"883_CR78","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ajhg.2018.08.005","volume":"103","author":"N Alirezaie","year":"2018","unstructured":"Alirezaie, N., Kernohan, K. D., Hartley, T., Majewski, J. & Hocking, T. D. ClinPred: prediction tool to identify disease-relevant nonsynonymous single-nucleotide variants. Am. J. Hum. Genet. 103, 474\u2013483 (2018).","journal-title":"Am. J. Hum. Genet."},{"key":"883_CR79","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/bioinformatics\/btx536","volume":"34","author":"MF Rogers","year":"2018","unstructured":"Rogers, M. F. et al. FATHMM-XF: accurate prediction of pathogenic point mutations via extended features. Bioinformatics 34, 511\u2013513 (2018).","journal-title":"Bioinformatics"},{"key":"883_CR80","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s41588-018-0167-z","volume":"50","author":"L Sundaram","year":"2018","unstructured":"Sundaram, L. et al. Predicting the clinical impact of human mutation with deep neural networks. Nat. Genet. 50, 1161\u20131170 (2018).","journal-title":"Nat. Genet."},{"key":"883_CR81","doi-asserted-by":"publisher","first-page":"e1008827","DOI":"10.1371\/journal.pgen.1008827","volume":"16","author":"CD Huber","year":"2020","unstructured":"Huber, C. D., Kim, B. Y. & Lohmueller, K. E. Population genetic models of GERP scores suggest pervasive turnover of constrained sites across mammalian evolution. PLoS Genet. 16, e1008827 (2020).","journal-title":"PLoS Genet."},{"key":"883_CR82","doi-asserted-by":"publisher","first-page":"W154","DOI":"10.1093\/nar\/gkaa288","volume":"48","author":"N Malhis","year":"2020","unstructured":"Malhis, N., Jacobson, M., Jones, S. J. M. & Gsponer, J. LIST-S2: taxonomy based sorting of deleterious missense mutations across species. Nucleic Acids Res. 48, W154\u2013W161 (2020).","journal-title":"Nucleic Acids Res."},{"key":"883_CR83","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41586-021-04043-8","volume":"599","author":"J Frazer","year":"2021","unstructured":"Frazer, J. et al. Disease variant prediction with deep generative models of evolutionary data. Nature 599, 91\u201395 (2021).","journal-title":"Nature"},{"key":"883_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20847-0","volume":"12","author":"H Qi","year":"2021","unstructured":"Qi, H. et al. MVP predicts the pathogenicity of missense variants by deep learning. Nat. Commun. 12, 510 (2021).","journal-title":"Nat. Commun."},{"key":"883_CR85","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.ajhg.2021.08.012","volume":"108","author":"Y Wu","year":"2021","unstructured":"Wu, Y., Li, R., Sun, S., Weile, J. & Roth, F. P. Improved pathogenicity prediction for rare human missense variants. Am. J. Hum. Genet. 108, 1891\u20131906 (2021).","journal-title":"Am. J. Hum. Genet."},{"key":"883_CR86","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s42256-022-00561-w","volume":"4","author":"H Zhang","year":"2022","unstructured":"Zhang, H., Xu, M. S., Fan, X., Chung, W. K. & Shen, Y. Predicting functional effect of missense variants using graph attention neural networks. Nat. Mach. Intell. 4, 1017\u20131028 (2022).","journal-title":"Nat. Mach. Intell."},{"key":"883_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01120-z","volume":"14","author":"C Li","year":"2022","unstructured":"Li, C., Zhi, D., Wang, K. & Liu, X. MetaRNN: differentiating rare pathogenic and rare benign missense SNVs and InDels using deep learning. Genome Med. 14, 115 (2022).","journal-title":"Genome Med."},{"key":"883_CR88","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg7492","volume":"381","author":"J Cheng","year":"2023","unstructured":"Cheng, J. et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science 381, eadg7492 (2023).","journal-title":"Science"},{"key":"883_CR89","doi-asserted-by":"publisher","unstructured":"Rives, A. et al. Biological structure and function emerge from scaling unsupervised learning to 250 million protein sequences. Proc. Natl. Acad. Sci. USA 118, https:\/\/doi.org\/10.1073\/pnas.2016239118 (2021).","DOI":"10.1073\/pnas.2016239118"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00883-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00883-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00883-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T13:09:34Z","timestamp":1749647374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00883-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["883"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-00883-x","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"6 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.M.H. is a Member of the Active Surveillance Movember Committee and received an honorarium from the Korean Urological Oncology Society for the 2024 Annual Conference as a guest speaker. Authors K.Z., K.G. and P.X.Y.S. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}